Management of IRIS

  • Authors: Irini Sereti, MD, MHS; Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • Pathogen-specific antimicrobials should be initiated or continued in patients diagnosed with IRIS
  • Corticosteroids are usually needed in serious or refractory IRIS cases
  • Use of prednisone has been shown to reduce IRIS symptoms in patients with paradoxical TB IRIS[Meintjes 2010]

Action required

Keywords: Cryptococcus, IRIS, Resource-Limited Settings, Tuberculosis, Viral Hepatitis Coinfection

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.